Hatice Ayça ATA KORKMAZ

Relationship between the earlobe crease and brain white matter abnormalities in apparently healthy subjects

Background/aim: In the present study we aimed to investigate whether the earlobe crease (ELC) might provide predictive informationabout white matter intensities (WMIs) in the brain that reflect brain aging.Materials and methods: A total of 350 individuals examined from January 2016 to July 2016 were screened. Patients with knowndemyelinating white matter disease, neurodegenerative disorders, cerebrovascular event history, or brain tumors were excluded fromthe study. Finally, 285 cases were included in the study. The four-point cerebral intensity classification system of Fazekas was used in theevaluation of the brain. The ELC was evaluated by inspection.Results: A total of 285 patients were enrolled consecutively. The incidence of WMI was significantly higher in patients with ELC thanthe others. Age (95% CI: 1.105–1.213, P < 0.001) and ELC (95% CI: 0.098–0.783, P = 0.015) were found as an independent determinantsof abnormal WMI. ELC predicted abnormal WMIs with 89% specificity and 62% sensitivity.Conclusion: The presence of an ELC may provide predictive information in terms of detecting abnormal WMIs with prognostic impactin apparently healthy subjects.

PDF

___

1. Fazekas F. Magnetic resonance signal abnormalities in asymptomatic individuals: their incidence and functional correlates. Eur Neurol 1989; 29: 164-168.
2. DeCarli C, Murphy DGM, Tranh M, Grady CL, Haxby JV, Gillette JA, Salerno JA, Gonzales-Aviles A, Honvitz B, Rapoport SI et al. The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 1995; 45: 2077-2084.
3. de Leeuw FE, de Groot JC, Achten E, Oudkerk M, Ramos LM, Heijboer R, Hofman A, Jolles J, van Gijn J, Breteler MM. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J Neurol Neurosurg Psychiatry 2001; 70: 9-14.
4. DeCarli C, Fletcher E, Ramey V, Harvey D, Jagust WJ. Anatomical mapping of white matter hyperintensities (WMI). Stroke 2005; 36: 50-55.
5. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, Radner H, Lechner H. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993; 43: 1683.
6. Whitman G, Tang T, Lin A, Baloh R. A prospective study of cerebral white matter abnormalities in older people with gait dysfunction. Neurology 2001; 57: 990-994.
7. De Leeuw F, de Groot JC, Oudkerk M, Witteman JCM, Hofman A, van Gijn J, Breteler MM. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 2000; 47: 145-151.
8. Barber R, Schelten P, Gholkar A, Ballard C, McKeith I, Ince P, Perry R, Brien JO. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer’s disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry 1999; 67: 66-72.
9. Williamson W, Lewandowski AJ, Forkert ND, Griffanti L, Betts J, Boardman H, Siepmann T, McKean D, Huckstep O, Francis JM et al. Association of cardiovascular risk factors with MRI indices of cerebrovascular structure and function and white matter hyperintensities in young adults. JAMA 2018; 320: 665- 673.
10. Wahlund L, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, Wallin A, Ader H, Leys D, Pantoni L et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001; 32: 1318-1322.
11. Inzitari D, Simoni M, Pracucci G, Poggesi A, Basile AM, Chabriat H, Erkinjuntti T, Fazekas F, Ferro JM, Hennerici M et al. Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med 2007; 167: 81-88.
12. Koedam EL, Lehmann M, van der Flier WM, Scheltens P, Pijnenburg YAL, Fox N, Barkhof F, Wattjes MP. Visual assessment of posterior atrophy development of a MRI rating scale. Eur Radiol 2011; 21: 2618-2625.
13. IBM Corp. IBM SPSS Statistics for Windows 20. Armonk, NY, USA: IBM Corp.; 2013.
14. Gorelick PB, Scuteri A, Black SE, DeCarli C, Greenberg SM, Iadecola C, Launer LJ, Laurent S, Lopez OL, Nyenhuis D et al. Vascular contributions to cognitive impairment and dementia. Stroke 2011; 42: 2672-2713.
15. Van Der Flier WM, Wiesje M, Barkhof F, Verdelho A, Madureira S, Pantoni L, Inzitari D, Erkinjuntti T, Crisby M, Waldemar G et al. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke 2005; 36: 2116- 2120.
16. Frank ST. Aural sign of coronary-artery disease. N Engl J Med 1973; 289: 327.
17. Dwivedi S, Jhamb R. Cutaneous markers of coronary artery disease. World Journal of cardiology 2010; 2: 262.
18. Lucenteforte E, Romoli M, Zagl G, Lucenteforte E, Romoli M, Zagli G, Gensini GF, Mugelli A, Vannacci A. Ear lobe crease as a marker of coronary artery disease: a meta-analysis. Int J Cardiol 2014; 175: 171-175.
19. Shmilovich H, Cheng VY, Rajani R, Dey D, Tamarappoo BK, Nakazato R, Smith TW, Otaki Y, Nakanishi R, Gransar H et al. Relation of diagonal ear lobe crease to the presence, extent, and severity of coronary artery disease determined by coronary computed tomography angiography. Am J Cardiol 2012; 109: 1283-1287.